Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2024-2032

  Hoyne, Gerard F ^a   Flening, Eleanor ^a   Yabas, Mehmet ^a   Teh, Charis ^a   Altin, John A ^a   Randall, Katrina ^a   Thien, Christine B F ^b   Langdon, Wallace Y ^b   Goodnow, Christopher C ^a  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CBL B PROTEIN; CBL PROTEIN; INSULIN; INTERLEUKIN 2; LYSOZYME; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CBL B DEFICIENCY; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SPECIFICITY; CLONAL ANERGY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME DEFICIENCY; GENE REPRESSION; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; MOUSE; NONHUMAN; PANCREAS CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONAL ANERGY; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FORKHEAD TRANSCRIPTION FACTORS; GENETIC PREDISPOSITION TO DISEASE; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN SPECIFICITY; PANCREAS; PROTO-ONCOGENE PROTEINS C-CBL; T-LYMPHOCYTES, REGULATORY;

EID: 79951836787     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002296     Document Type: Article

References (47)

1. Anderson, M. S., E. S. Venanzi, L. Klein, Z. Chen, S. P. Berzins, S. J. Turley, H. von Boehmer, R. Bronson, A. Dierich, C. Benoist, and D. Mathis. 2002. Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401. (Pubitemid 35346134)
2. Finnish-German APECED Consortium. 1997. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nat. Genet. 17: 399-403.
3. Liston, A., D. H. Gray, S. Lesage, A. L. Fletcher, J. Wilson, K. E. Webster, H. S. Scott, R. L. Boyd, L. Peltonen, and C. C. Goodnow. 2004. Gene dosage - limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J. Exp. Med. 200: 1015-1026.
4. Liston, A., S. Lesage, J. Wilson, L. Peltonen, and C. C. Goodnow. 2003. Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4: 350-354.
5. Nagamine, K., P. Peterson, H. S. Scott, J. Kudoh, S. Minoshima, M. Heino, K. J. Krohn, M. D. Lalioti, P. E. Mullis, S. E. Antonarakis, et al. 1997. Positional cloning of the APECED gene. Nat. Genet. 17: 393-398.
6. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
7. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol. 6: 1152-1159.
8. + regulatory T cells. Nat. Immunol. 4: 330-336.
9. Fontenot, J. D., J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6: 1142-1151.
10. + regulatory T cell function. J. Exp. Med. 196: 851-857.
11. + T regulatory cells. Nat. Immunol. 4: 337-342.
12. Liston, A., O. M. Siggs, and C. C. Goodnow. 2007. Tracing the action of IL-2 in tolerance to islet-specific antigen. Immunol. Cell Biol. 85: 338-342.
13. Sharfe, N., H. K. Dadi, M. Shahar, and C. M. Roifman. 1997. Human immune disorder arising from mutation of the a chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 94: 3168-3171.
14. Wildin, R. S., F. Ramsdell, J. Peake, F. Faravelli, J. L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27: 18-20.
15. Choisy-Rossi, C. M., T. M. Holl, M. A. Pierce, H. D. Chapman, and D. V. Serreze. 2004. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience. J. Immunol. 173: 3791-3800.
16. Kishimoto, H., and J. Sprent. 2001. A defect in central tolerance in NOD mice. Nat. Immunol. 2: 1025-1031.
17. Lesage, S., S. B. Hartley, S. Akkaraju, J. Wilson, M. Townsend, and C. C. Goodnow. 2002. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J. Exp. Med. 196: 1175-1188.
18. Liston, A., S. Lesage, D. H. Gray, L. A. O'Reilly, A. Strasser, A. M. Fahrer, R. L. Boyd, J. Wilson, A. G. Baxter, E. M. Gallo, et al. 2004. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21: 817-830.
19. Zucchelli, S., P. Holler, T. Yamagata, M. Roy, C. Benoist, and D. Mathis. 2005. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22: 385-396. (Pubitemid 40387479)
20. Yokoi, N., Y. Fujiwara, H. Y. Wang, M. Kitao, C. Hayashi, T. Someya, M. Kanamori, Y. Oiso, N. Tajima, Y. Yamada, et al. 2008. Identification and functional analysis of CBLB mutations in type 1 diabetes. Biochem. Biophys. Res. Commun. 368: 37-42.
21. Yokoi, N., C. Hayashi, Y. Fujiwara, H. Y. Wang, and S. Seino. 2007. Genetic reconstitution of autoimmune type 1 diabetes with two major susceptibility genes in the rat. Diabetes 56: 506-512.
22. Yokoi, N., K. Komeda, H. Y. Wang, H. Yano, K. Kitada, Y. Saitoh, Y. Seino, K. Yasuda, T. Serikawa, and S. Seino. 2002. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat. Genet. 31: 391-394.
23. Jeon, M. S., A. Atfield, K. Venuprasad, C. Krawczyk, R. Sarao, C. Elly, C. Yang, S. Arya, K. Bachmaier, L. Su, et al. 2004. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21: 167-177. (Pubitemid 39094047)
24. Liu, Y. C., and H. Gu. 2002. Cbl and Cbl-b in T-cell regulation. Trends Immunol. 23: 140-143. (Pubitemid 34178296)
25. Thien, C. B., and W. Y. Langdon. 2001. Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2: 294-307.
26. Thien, C. B., F. Walker, and W. Y. Langdon. 2001. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. Mol. Cell 7: 355-365.
27. Chiang, Y. J., H. K. Kole, K. Brown, M. Naramura, S. Fukuhara, R. J. Hu, I. K. Jang, J. S. Gutkind, E. Shevach, and H. Gu. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403: 216-220. (Pubitemid 30050967)
28. Naramura, M., I. K. Jang, H. Kole, F. Huang, D. Haines, and H. Gu. 2002. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat. Immunol. 3: 1192-1199.
29. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveirados-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216. (Pubitemid 30050966)
30. Chiang, J. Y., I. K. Jang, R. Hodes, and H. Gu. 2007. Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J. Clin. Invest. 117: 1029-1036.
31. Li, D., I. Gál, C. Vermes, M. L. Alegre, A. S. Chong, L. Chen, Q. Shao, V. Adarichev, X. Xu, T. Koreny, et al. 2004. Cutting edge: Cbl-b - one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J. Immunol. 173: 7135-7139. (Pubitemid 39628148)
32. Ou, R., M. Zhang, L. Huang, and D. Moskophidis. 2008. Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection. J. Virol. 82: 3353-3368. (Pubitemid 351429913)
33. Zhang, J., T. Bárdos, D. Li, I. Gál, C. Vermes, J. Xu, K. Mikecz, A. Finnegan, S. Lipkowitz, and T. T. Glant. 2002. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169: 2236-2240.
34. Qiao, G., Z. Li, L. Molinero, M. L. Alegre, H. Ying, Z. Sun, J. M. Penninger, and J. Zhang. 2008. T-cell receptor-induced NF-κB activation is negatively regulated by E3 ubiquitin ligase Cbl-b. Mol. Cell. Biol. 28: 2470-2480.
35. Fang, D., and Y. C. Liu. 2001. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2: 870-875.
36. Harada, Y., Y. Harada, C. Elly, G. Ying, J. H. Paik, R. A. DePinho, and Y. C. Liu. 2010. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 207: 1381-1391.
37. Heissmeyer, V., F. Macián, S. H. Im, R. Varma, S. Feske, K. Venuprasad, H. Gu, Y. C. Liu, M. L. Dustin, and A. Rao. 2004. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5: 255-265.
38. Mueller, D. L. 2004. E3 ubiquitin ligases as T cell anergy factors. Nat. Immunol. 5: 883-890.
39. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
40. Macián, F., F. García-Cózar, S. H. Im, H. F. Horton, M. C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731. (Pubitemid 34722268)
41. Akkaraju, S., W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, and C. C. Goodnow. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7: 255-271.
42. Allen, P. M., G. R. Matsueda, R. J. Evans, J. B. Dunbar, Jr., G. R. Marshall, and E. R. Unanue. 1987. Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope. Nature 327: 713-715.
43. -/- mice. J. Immunol. 173: 1059-1065.
44. Wohlfert, E. A., L. Gorelik, R. Mittler, R. A. Flavell, and R. B. Clark. 2006. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-β sensitivity in vitro and in vivo. J. Immunol. 176: 1316-1320.
45. Bygrave, A. E., K. L. Rose, J. Cortes-Hernandez, J. Warren, R. J. Rigby, H. T. Cook, M. J. Walport, T. J. Vyse, and M. Botto. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2: E243.
46. Goodnow, C. C., J. Sprent, B. Fazekas de St. Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597.
47. Siggs, O. M., L. E. Makaroff, and A. Liston. 2006. The why and how of thymocyte negative selection. Curr. Opin. Immunol. 18: 175-183.